Description
This product utilizes engineered Tregs that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IRO326). We employs the Lentivirus (SP6-Cy2-IL-17-PstI) vector components and the SynExpress system of the single base pair Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
IRO326
Species Reactivity
Human
Cell Source
Engineered Tregs
Sensor Gene
Cy2
Promoter
SP6
Effector Gene
IL-17
Insertion Sites
PstI
Gene Modification
Knock-in
Modification Domain
Single base pair
Carrier Type
Lentivirus
Transformation Accuracy
0.97
Cell Culture
Microcarrier Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.